J
CLINICAL RESULTS: Joe Vinson, Ph.D. at the University of Scranton(HEART
HEALHT)
[email protected]
In a recent clinical trial conducted by Dr. Joe Vinson at the
University of Scranton, Relìv CardioSentials significantly decreased
total cholesterol, LDL (bad) cholesterol and triglycerides in a sub-set
of test subjects with high cholesterol. In addition, Relìv
CardioSentials increased HDL (good) cholesterol and reduced blood
glucose levels.
for all the information:
http://www.reliv.com/docs/nutritionals/CardioSentialsBrochure.pdf
Relìv CardioSentials Takes Aim Relìv recognizes that simply lowering
cholesterol isn't enough. Total heart health The Relìv Clinical
Trial:
******************************RESULTS*******************************************************
Joe Vinson, Ph.D. and Professor of Chemistry at the University of
Scranton, conducted a 16-week randomized double-blind,
placebo-controlled crossover study (the "gold standard" in clinical
trials) to determine the safety and effectiveness of Relìv
CardioSentials in reducing key risk factors for cardiovascular disease.
The study tested two groups - individuals taking statin medications
and individuals who were not on statins. Both groups experienced
significant antioxidant benefits from Relìv CardioSentials that
supports heart health by defending against lipid oxidation. In
addition:
Non-Statin Group - Taken once daily, Relìv CardioSentials
significantly reduced total cholesterol, LDL (bad) cholesterol and
glucose, and raised HDL (good) cholesterol and lowered triglycerides.
It significantly decreased the overall risk factor for heart disease.
Statin Group - Relìv CardioSentials caused no adverse interaction
with statin medication, and members of the group saw improvements in
their average risk factor due to a significant decrease in LDL (bad
cholesterol). These subjects also experienced a glucose decrease.
Risk Reduction - According to the clinical results, Relìv's total
heart health formula was also shown to reduce the 10-year risk for
developing cardiovscular disease, based on the risk assessment tool
developed by the "National cholesterol education program"
recent clinical trial conducted by Dr. Joe Vinson at the University of
Scranton, Relìv CardioSentials significantly decreased total
cholesterol, LDL (bad) cholesterol and triglycerides in a sub-set of
test subjects with high cholesterol. In addition, Relìv CardioSentials
increased HDL (good) cholesterol and reduced blood glucose levels.
also shown to reduce the 10-year risk for developing cardiovascular
disease, on the Risk Assessment tool developed by the "National
Cholesterol Education Program." The effects of the product on heart
disease were all beneficial to the subjects. These include lipids,
lipid oxidation and glucose. In other words, the product improves total
heart health in people who have high cholesterol, even those taking
statins.
Dr. Joe Vinson Professor of Chemistry, University of Scranton
FOR MORE INFORMATION : OR TO ORDER send me an e-mail:
[email protected]
HEALHT)
[email protected]
In a recent clinical trial conducted by Dr. Joe Vinson at the
University of Scranton, Relìv CardioSentials significantly decreased
total cholesterol, LDL (bad) cholesterol and triglycerides in a sub-set
of test subjects with high cholesterol. In addition, Relìv
CardioSentials increased HDL (good) cholesterol and reduced blood
glucose levels.
for all the information:
http://www.reliv.com/docs/nutritionals/CardioSentialsBrochure.pdf
Relìv CardioSentials Takes Aim Relìv recognizes that simply lowering
cholesterol isn't enough. Total heart health The Relìv Clinical
Trial:
******************************RESULTS*******************************************************
Joe Vinson, Ph.D. and Professor of Chemistry at the University of
Scranton, conducted a 16-week randomized double-blind,
placebo-controlled crossover study (the "gold standard" in clinical
trials) to determine the safety and effectiveness of Relìv
CardioSentials in reducing key risk factors for cardiovascular disease.
The study tested two groups - individuals taking statin medications
and individuals who were not on statins. Both groups experienced
significant antioxidant benefits from Relìv CardioSentials that
supports heart health by defending against lipid oxidation. In
addition:
Non-Statin Group - Taken once daily, Relìv CardioSentials
significantly reduced total cholesterol, LDL (bad) cholesterol and
glucose, and raised HDL (good) cholesterol and lowered triglycerides.
It significantly decreased the overall risk factor for heart disease.
Statin Group - Relìv CardioSentials caused no adverse interaction
with statin medication, and members of the group saw improvements in
their average risk factor due to a significant decrease in LDL (bad
cholesterol). These subjects also experienced a glucose decrease.
Risk Reduction - According to the clinical results, Relìv's total
heart health formula was also shown to reduce the 10-year risk for
developing cardiovscular disease, based on the risk assessment tool
developed by the "National cholesterol education program"
recent clinical trial conducted by Dr. Joe Vinson at the University of
Scranton, Relìv CardioSentials significantly decreased total
cholesterol, LDL (bad) cholesterol and triglycerides in a sub-set of
test subjects with high cholesterol. In addition, Relìv CardioSentials
increased HDL (good) cholesterol and reduced blood glucose levels.
also shown to reduce the 10-year risk for developing cardiovascular
disease, on the Risk Assessment tool developed by the "National
Cholesterol Education Program." The effects of the product on heart
disease were all beneficial to the subjects. These include lipids,
lipid oxidation and glucose. In other words, the product improves total
heart health in people who have high cholesterol, even those taking
statins.
Dr. Joe Vinson Professor of Chemistry, University of Scranton
FOR MORE INFORMATION : OR TO ORDER send me an e-mail:
[email protected]